About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Recherche
›
Press releases
About
Our mission
Governance
Partners
Science
Our Genome Engineering Platform
TALEN® Technology
In-House Manufacturing
Pipeline
Product Candidates
Investors
IR Overview
News
Press releases
Events and Webcasts
Presentations
Corporate presentations
Scientific presentations
Scientific publications
Corporate Governance
Board of Directors
Executive Committee
External Auditors
Governance Documents
General meetings
Financial Information
SEC filings
Financial statements
Voting Rights & Share Capital
Stock information
Shareholders Services
IR Inquiries
IR FAQ
Careers
Our culture
Job opportunities
Contact us
FR
Press releases
All
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
10
Dec 2018
21:30 E.S.T.
Cellectis Appoints William Monteith as Senior Vice President U.S. Manufacturing
Read more
13
Nov 2018
21:30 E.S.T.
Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2018
Read more
19
Sep 2018
20:30 E.S.T.
CAR-T Pioneer Dr. Stephan A. Grupp to Join Cellectis Clinical Advisory Board
Read more
18
Sep 2018
20:30 E.S.T.
Calyxt Appoints CEO, Jim Blome, Former President & CEO of Bayer CropScience LP
Read more
22
Aug 2018
12:00 E.S.T.
Calyxt Names Biotech Veteran and Board of Directors Member Dr. Yves J. Ribeill as Interim CEO
Read more
2
Aug 2018
20:30 E.S.T.
Cellectis Appoints Stefan Scherer M.D., Ph.D., as Senior Vice President Clinical Development and Deputy Chief Medical Officer
Read more
1
Aug 2018
20:30 E.S.T.
Cellectis Reports Financial Results for 2nd Quarter and First Six Months 2018
Read more
27
Jun 2018
20:30 E.S.T.
Cellectis S.A. Reports Results from Annual General Meeting Held on June 26, 2018
Read more
12
Jun 2018
20:30 E.S.T.
Cellectis Publishes Novel Methods to Improve the Clinical Use of Chimeric Antigen Receptor T-Cell Therapy in Scientific Reports
Read more
8
Jun 2018
21:45 E.S.T.
Shareholders’ General Meeting of June 26, 2018
Read more
Posts pagination
1
2
3
4
NEXT →
Press contacts
For more information on any story, or for press enquiries, get in touch with our communication team
CONTACT US